Alterity Therapeutics Statistics
NASDAQ: ATHEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.52-0.135 (-8.16%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Alterity Therapeutics by the numbers
Alterity Therapeutics has a market capitalization of $29.0 million based on 19.09M shares outstanding. With trailing EPS of $-0.90, Alterity Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.3% below its 50-day average and 60.9% below its 200-day average.
Average daily trading volume is 89.63K shares, or about $136,244 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATHE valuation vs. peer median
| Metric | ATHE | Peer median | Difference |
|---|---|---|---|
| Market cap | $29.02M | $28.99M | +0% |
| Avg. volume | 89.63K | 153.03K | -41% |
Peer median across 8 companies: RNTX, AYTU, NNVC, NXTC, PMN, SER, EDSA, NSRX.
Valuation
- Market cap
- $29.02M
- EPS (TTM)
- $-0.90
- Shares outstanding
- 19.09M
Price and trading
- Previous close
- 1.66
- Open
- 1.52
- Day range
- 1.52 – 1.64
- 52-week range
- 1.52 – 5.89
- 52-week change
- -56.70%
- Beta
- —
- Volume
- 20.24K
- Average volume
- 89.63K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2025
Additional statistics
- Market Cap
- 29.02M
- Forward Pe
- -1.82
- Eps
- -0.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.89
- Week52 Low
- 1.52
- Avg Volume
- 89,634.00
- Shares Outstanding
- 19.09M
- Ma50
- 2.78
- Ma200
- 3.89
- Earnings Date
- Aug 4, 2025
- Pct From52w High
- -74.19%
- Pct From52w Low
- 0.00%